BIM
PETX

BlackRock Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

BlackRock Investment Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$933K Sell
129,892
-1,051
-0.8% -$8.5K ﹤0.01% 2733
2016
Q3 		$1.23M Buy
130,943
+5,885
+5% +$48.9K ﹤0.01% 2535
2016
Q2 		$790K Buy
125,058
+17,157
+16% +$110K ﹤0.01% 2793
2016
Q1 		$596K Buy
107,901
+1,843
+2% +$6.93K ﹤0.01% 2819
2015
Q4 		$592K Buy
106,058
+1,061
+1% +$7.01K ﹤0.01% 2933
2015
Q3 		$888K Sell
104,997
-1,883
-2% -$31.9K ﹤0.01% 2678
2015
Q2 		$1.62M Buy
106,880
+23,389
+28% +$338K ﹤0.01% 2405
2015
Q1 		$1.34M Buy
83,491
+1,266
+2% +$22.5K ﹤0.01% 2326
2014
Q4 		$1.47M Buy
82,225
+326
+0.4% +$4.06K ﹤0.01% 2278
2014
Q3 		$822K Buy
81,899
+12,117
+17% +$147K ﹤0.01% 2653
2014
Q2 		$1.09M Buy
69,782
+46,979
+206% +$666K ﹤0.01% 2543
2014
Q1 		$423K Buy
22,803
+3,952
+21% +$79.2K ﹤0.01% 3040
2013
Q4 		$360K Buy
18,851
+4,137
+28% +$84K ﹤0.01% 3101
2013
Q3 		$240K Buy
+14,714
New +$155K ﹤0.01% 3155

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's PETX Position: Q4 2016 in Review

BlackRock Investment Management reduced its Aratana Therapeutics, Inc. (PETX) stake by 0.8% in Q4 2016, selling an estimated $8.5K and leaving 129,892 shares worth $933K. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

BlackRock Investment Management first reported a position in PETX in Q3 2013 and has held it in 14 quarters since. The position peaked at $1.62M in Q2 2015. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • BlackRock Investment Management held 129,892 shares of Aratana Therapeutics, Inc. worth $933K as of Q4 2016.
  • BlackRock Investment Management sold 1,051 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $8.5K.
  • Aratana Therapeutics, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2733 holding.
  • BlackRock Investment Management first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Investment Management's Aratana Therapeutics, Inc. position peaked at $1.62M in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.